Point of care (POC) diagnostics refers to medical tests that can be performed at or near the site of patient care, such as in a hospital, doctor's office, or even in a patient's home. POC diagnostics can include blood glucose monitoring, pregnancy testing, and infectious disease testing, among others.
The global POC diagnostics market is expected to grow from ~$38.1 billion in 2027, at a compound annual growth rate (CAGR) of +6% during the forecast period.
F. Hoffmann-La Roche Ltd.
Danaher
BD
Qiagen
Abbott
Siemens Healthcare AG
bioMerieux SA
Zoetis, Inc.
Instrumentation Laboratory
Nova Biomedical
Quidel Corp.
Trividia Health, Inc.
Sekisui Diagnostics
Nipro Corp.
Trinity Biotech
Orasure Technologies, Inc.
Spectral Medical, Inc.
One major trend in the POC diagnostics market is the increasing demand for rapid and accurate diagnostic tests, particularly for infectious diseases such as COVID-19. The COVID-19 pandemic has highlighted the importance of POC diagnostics in quickly identifying and treating infected patients. Another trend is the development of more sophisticated POC diagnostic tests that can detect multiple diseases or biomarkers in a single test.
The increasing prevalence of chronic diseases such as diabetes and cancer is also driving the growth of the POC diagnostics market. POC diagnostic tests can help patients monitor their conditions more closely and make more informed decisions about their health.
One major opportunity in the POC diagnostics market is the potential for new diagnostic tests to address unmet medical needs. For example, there is a growing demand for POC tests that can quickly diagnose sepsis, a potentially life-threatening condition that can be difficult to detect.
However, there are also several threats to the POC diagnostics market. One threat is the potential for inaccurate or unreliable POC diagnostic tests, which can lead to misdiagnosis and inappropriate treatment. Another threat is the competition from alternative diagnostic technologies, such as laboratory-based tests or molecular diagnostics.
Regulatory and legal issues are a major concern for companies operating in the POC diagnostics market. Companies must comply with strict regulations regarding the safety and efficacy of their diagnostic tests, and must obtain regulatory approval before marketing their products.
In addition, there are concerns about the reimbursement policies for POC diagnostic tests. Some insurance providers may not cover the cost of certain POC tests, which can limit patient access to these important diagnostic tools.
The target demographics for the POC diagnostics market vary depending on the type of diagnostic test. For example, blood glucose monitoring is primarily used by patients with diabetes, while infectious disease testing may be used by a wider range of patients.
Pricing trends in the POC diagnostics market also vary depending on the type of test and the target demographic. Some POC tests, such as blood glucose monitors, are relatively inexpensive and widely available, while others, such as molecular diagnostic tests, can be more expensive and require specialized equipment.
Overall, the global POC diagnostics market is expected to continue to grow in the coming years, driven by factors such as increasing demand for rapid and accurate diagnostic tests, the growing prevalence of chronic diseases, and the development of more sophisticated POC diagnostic tests.
F. Hoffmann-La Roche Ltd.
Danaher
BD
Qiagen
Abbott
Siemens Healthcare AG
bioMerieux SA
Zoetis, Inc.
Instrumentation Laboratory
Nova Biomedical
Quidel Corp.
Trividia Health, Inc.
Sekisui Diagnostics
Nipro Corp.
Trinity Biotech
Orasure Technologies, Inc.
Spectral Medical, Inc.
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
AI® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2025-26 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market